Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 2376-2383

  Yoshida, Souichi ^a   Harada, Tasuku ^a   Iwabe, Tomio ^a   Taniguchi, Fuminori ^a   Fujii, Akiko ^a   Sakamoto, Yasuko ^a   Yamauchi, Nobuhiro ^a   Shiota, Goshi ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GENE PRODUCT; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOMA CELL; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; STROMA CELL; TUMOR GROWTH;

EID: 0036090312     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.5.8483     Document Type: Article

References (40)

1. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo
2. Recent advances in chemoprevention of cancer
3. Landscaping the cancer terrain
4. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats
5. Molecular cloning and expression of human hepatocyte growth factor
6. Structure and function of hepatocyte growth factor
7. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
8. Differential tubulogenic and branching morphogenic activities of growth factors
9. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
10. Scatter factor induces blood vessel formation in vivo
11. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
12. Hepatocyte growth factor stimulated proliferation, migration, and lumen formation of human endometrial epithelial cells in vitro
13. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors
14. Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met
15. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
16. Overexpression of the met/HGF receptor in renal cell carcinomas
17. Expression of the c-Met/HGF receptor in human breast carcinoma: Correlation with tumor progression
18. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma
19. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma
20. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions
21. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts
22. Menstrual cycle-specific inhibition of the proliferation of endometrial stromal cells by interleukin 6 and its soluble receptor
23. Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis
24. Expression of hepatocyte growth factor and c-met receptor in gastric mucosa during gastric ulcer healing
25. Hepatocyte growth factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells
26. Hepatocyte growth factor/scatter factor expression in human mammary epithelium
27. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures
28. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor
29. Heparin sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met
30. Expression of hepatocyte growth factor and its receptor c-met in the ovine uterus
31. Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetylcarbamoyl) fumagillol (TNP-470; AGM-1470)
32. Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: An export-dependent mechanism of action
33. Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: Evidence for paracrine and autocrine action
34. Expression of hepatocyte growth factor in cultured human endometrial stromal cells is induced through a protein kinase C-dependent pathway
35. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: Localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia
36. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts
37. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration
38. Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor
39. Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor
40. Modulation of hepatocyte growth factor gene expression by estrogen in mouse ovary